Smart solution: Stop ‘SMART’ Prices Act Before it Kills Medical Innovation & Jobs

Share This :

Business leaders and life science advocates urged lawmakers to oppose federal drug pricing legislation that would stymie life-saving research, slash billions from California’s economy and wipe out more than 200,000 biopharmaceutical jobs statewide.

PRESS RELEASE - BizFed Opposes Drug Pricing Restrictions

Related New in Health Care